Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL Gains 6%; BSE HEALTHCARE Index Down 0.1%
Wed, 27 Nov 9:56

INDRAPRASTHA MEDICAL Gains 6%; BSE HEALTHCARE Index Down 0.1%Image source: asbe/www.istockphoto.com

INDRAPRASTHA MEDICAL share price has zoomed 6% and is presently trading at Rs 454.6.

Meanwhile, the BSE HEALTHCARE index is at 43,071.1 (down 0.1%).

Among the top gainers in the BSE HEALTHCARE index today are ASTER DM HEALTHCARE (up 3.0%) and ASTRAZENECA PHARMA (up 1.1%).

POLY MEDICURE (down 3.0%) and GRANULES INDIA (down 2.2%) are among the top losers today.

Over the last one year, INDRAPRASTHA MEDICAL has moved up from Rs 218.1 to Rs 454.6, registering a gain of Rs 236.5 (up 108.5%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,654.9 to 43,071.1, registering a gain of 45.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 163.4%), SUVEN PHARMACEUTICALS (up 97.4%) and Glenmark Pharma (up 96.9%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,964.1 .

The top losers among the BSE Sensex today are Indusind Bank (down 1.3%) and Bharti Airtel (down 1.1%). The most traded stocks in the BSE Sensex are NTPC and Tata Steel.

In the meantime, NSE Nifty is at 24,222.7 (up 0.1%). Bharat Electronics and Adani Enterprises are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,174.2 to 79,964.1, registering a gain of 13,789.9 points (up 20.8%).

INDRAPRASTHA MEDICAL Financial Update...

INDRAPRASTHA MEDICAL net profit grew 29.1% YoY to Rs 424 million for the quarter ended September 2024, compared to a profit of Rs 329 million a year ago. Net sales rose 10.4% to Rs 3,498 million during the period as against Rs 3,170 million in July-September 2023.

For the year ended March 2024, INDRAPRASTHA MEDICAL reported 43.9% increase in net profit to Rs 1,240 million compared to net profit of Rs 862 million during FY23. Revenue of the company grew 13.3% to Rs 12,447 million during FY24.

The current Price to earnings ratio of INDRAPRASTHA MEDICAL, based on rolling 12 month earnings, stands at 28.2.


Equitymaster requests your view! Post a comment on "INDRAPRASTHA MEDICAL Gains 6%; BSE HEALTHCARE Index Down 0.1%". Click here!